Drugmaker Gilead Sciences Inc. named Roche Holding AG’s Daniel O’Day as the company’s new chief executive, tapping an industry veteran to fill a management vacuum.
Akorn Inc. said the company’s chief executive officer would retire following the drugmaker’s inability to salvage a takeover deal with Germany’s Fresenius SE.
Independent, full-service agency Sandbox announced the hiring of Nick Rambke and Tracy Draksler Brown as SVPs of client services.
REALITYRx Communication announced that Scott Greisler joined the agency in the role of SVP, Management Supervisor.
Agency to step up strategic media planning and buying Chestertown, MD, October 24, 2018 – Benchworks is pleased to announce that Karima Sharif has joined the company as Senior Vice President, Media Director. She will lead all strategic media planning and nonpersonal promotion (NPP) services for clients. Karima joins Benchworks with a wide depth and […]
Citing structural simplification, Pfizer announced plans to cut the company’s global staffing by about 2 percent, primarily through voluntary layoffs and early retirement through the end of 2018 and early in 2019.
Novo Nordisk is in advanced talks to acquire assets to bolster the company’s struggling biopharma business after the drugmaker announced the hiring of an AstraZeneca executive to head the unit.
Cherie Davies joined FCB Chicago as SVP, Group Creative Director.
Fingerpaint opened an office in Morristown, N.J., heading by Mark Willmann. The healthcare agency’s first office in New Jersey joins other locations in New York, Pennsylvania, Arizona, and Ohio.
Pfizer announced the company’s succession plan for when Ian Read steps down as chief executive officer on January 1, 2019.